ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sustained Release Injectables Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-2E11924
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Sustained Release Injectables Market Research Report 2022
BUY CHAPTERS

Global Sustained Release Injectables Market Research Report 2024

Code: QYRE-Auto-2E11924
Report
February 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Ascendis Pharma
Astrazeneca plc
Aurobindo
Avadel
Alkermes plc
Amylin Pharmaceuticals
BioMarin
Camurus AB
Critical Pharmaceuticals
DURECT
Eli Lilly
Enzon, Inc.
Ipsen S A
Innocore Pharmaceuticals
Janssen
Merck
NanOlogy
Novartis
Pacira
PhaseBio Pharmaceuticals
Recipharm
Roche
Sanofi
Xbrane Biopharma
Livzon Pharm
Luye Pharma Group
AntriaBio
Oakwood Laboratories/PharmaSophia
OctoPlus
Taiwan Liposome Company (TLC)

Sustained Release Injectables Market

It is a preparation with better therapeutic effect by delaying drug release rate from the formulation and reducing drug absorption rate into the body.
The global Sustained Release Injectables market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Sustained Release Injectables is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sustained Release Injectables is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Sustained Release Injectables in Diabetes is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Sustained Release Injectables include AntriaBio, Ascendis Pharma, AstraZeneca, Aurobindo, Avadel, Alkermes, Amylin Pharmaceuticals, Biomarin and Camurus, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sustained Release Injectables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sustained Release Injectables.

Report Scope

The Sustained Release Injectables market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sustained Release Injectables market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sustained Release Injectables companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Sustained Release Injectables Market Report

Report Metric Details
Report Name Sustained Release Injectables Market
Segment by Type
  • Microparticles
  • Implants
  • Gels
Segment by Application
  • Diabetes
  • Leukemia
  • Acromegaly
  • Ophthalmology
  • CNS
  • Rheumatology
  • Oncology
  • Reproductive Health
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AntriaBio, Ascendis Pharma, AstraZeneca, Aurobindo, Avadel, Alkermes, Amylin Pharmaceuticals, Biomarin, Camurus, Critical Pharmaceuticals, Durect, Eli Lilly, Enzon, Ipsen, InnoCore Pharmaceuticals, Janssen, Merck, NanOlogy, Novartis, Oakwood Laboratories/PharmaSophia, OctoPlus, Pacira, PhaseBio Pharmaceuticals, Recipharm AB, Roche, Sanofi, Taiwan Liposome Company (TLC), Xbrane Biopharma, Livzon Pharm, Luye Pharma Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Sustained Release Injectables companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Sustained Release Injectables Market report?

Ans: The main players in the Sustained Release Injectables Market are AntriaBio, Ascendis Pharma, AstraZeneca, Aurobindo, Avadel, Alkermes, Amylin Pharmaceuticals, Biomarin, Camurus, Critical Pharmaceuticals, Durect, Eli Lilly, Enzon, Ipsen, InnoCore Pharmaceuticals, Janssen, Merck, NanOlogy, Novartis, Oakwood Laboratories/PharmaSophia, OctoPlus, Pacira, PhaseBio Pharmaceuticals, Recipharm AB, Roche, Sanofi, Taiwan Liposome Company (TLC), Xbrane Biopharma, Livzon Pharm, Luye Pharma Group

What are the Application segmentation covered in the Sustained Release Injectables Market report?

Ans: The Applications covered in the Sustained Release Injectables Market report are Diabetes, Leukemia, Acromegaly, Ophthalmology, CNS, Rheumatology, Oncology, Reproductive Health, Others

What are the Type segmentation covered in the Sustained Release Injectables Market report?

Ans: The Types covered in the Sustained Release Injectables Market report are Microparticles, Implants, Gels

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sustained Release Injectables Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Microparticles
1.2.3 Implants
1.2.4 Gels
1.3 Market by Application
1.3.1 Global Sustained Release Injectables Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diabetes
1.3.3 Leukemia
1.3.4 Acromegaly
1.3.5 Ophthalmology
1.3.6 CNS
1.3.7 Rheumatology
1.3.8 Oncology
1.3.9 Reproductive Health
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sustained Release Injectables Market Perspective (2019-2030)
2.2 Sustained Release Injectables Growth Trends by Region
2.2.1 Global Sustained Release Injectables Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sustained Release Injectables Historic Market Size by Region (2019-2024)
2.2.3 Sustained Release Injectables Forecasted Market Size by Region (2025-2030)
2.3 Sustained Release Injectables Market Dynamics
2.3.1 Sustained Release Injectables Industry Trends
2.3.2 Sustained Release Injectables Market Drivers
2.3.3 Sustained Release Injectables Market Challenges
2.3.4 Sustained Release Injectables Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sustained Release Injectables Players by Revenue
3.1.1 Global Top Sustained Release Injectables Players by Revenue (2019-2024)
3.1.2 Global Sustained Release Injectables Revenue Market Share by Players (2019-2024)
3.2 Global Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sustained Release Injectables Revenue
3.4 Global Sustained Release Injectables Market Concentration Ratio
3.4.1 Global Sustained Release Injectables Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sustained Release Injectables Revenue in 2023
3.5 Sustained Release Injectables Key Players Head office and Area Served
3.6 Key Players Sustained Release Injectables Product Solution and Service
3.7 Date of Enter into Sustained Release Injectables Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sustained Release Injectables Breakdown Data by Type
4.1 Global Sustained Release Injectables Historic Market Size by Type (2019-2024)
4.2 Global Sustained Release Injectables Forecasted Market Size by Type (2025-2030)
5 Sustained Release Injectables Breakdown Data by Application
5.1 Global Sustained Release Injectables Historic Market Size by Application (2019-2024)
5.2 Global Sustained Release Injectables Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sustained Release Injectables Market Size (2019-2030)
6.2 North America Sustained Release Injectables Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sustained Release Injectables Market Size by Country (2019-2024)
6.4 North America Sustained Release Injectables Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sustained Release Injectables Market Size (2019-2030)
7.2 Europe Sustained Release Injectables Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sustained Release Injectables Market Size by Country (2019-2024)
7.4 Europe Sustained Release Injectables Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sustained Release Injectables Market Size (2019-2030)
8.2 Asia-Pacific Sustained Release Injectables Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sustained Release Injectables Market Size by Region (2019-2024)
8.4 Asia-Pacific Sustained Release Injectables Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sustained Release Injectables Market Size (2019-2030)
9.2 Latin America Sustained Release Injectables Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sustained Release Injectables Market Size by Country (2019-2024)
9.4 Latin America Sustained Release Injectables Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sustained Release Injectables Market Size (2019-2030)
10.2 Middle East & Africa Sustained Release Injectables Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sustained Release Injectables Market Size by Country (2019-2024)
10.4 Middle East & Africa Sustained Release Injectables Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AntriaBio
11.1.1 AntriaBio Company Detail
11.1.2 AntriaBio Business Overview
11.1.3 AntriaBio Sustained Release Injectables Introduction
11.1.4 AntriaBio Revenue in Sustained Release Injectables Business (2019-2024)
11.1.5 AntriaBio Recent Development
11.2 Ascendis Pharma
11.2.1 Ascendis Pharma Company Detail
11.2.2 Ascendis Pharma Business Overview
11.2.3 Ascendis Pharma Sustained Release Injectables Introduction
11.2.4 Ascendis Pharma Revenue in Sustained Release Injectables Business (2019-2024)
11.2.5 Ascendis Pharma Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Sustained Release Injectables Introduction
11.3.4 AstraZeneca Revenue in Sustained Release Injectables Business (2019-2024)
11.3.5 AstraZeneca Recent Development
11.4 Aurobindo
11.4.1 Aurobindo Company Detail
11.4.2 Aurobindo Business Overview
11.4.3 Aurobindo Sustained Release Injectables Introduction
11.4.4 Aurobindo Revenue in Sustained Release Injectables Business (2019-2024)
11.4.5 Aurobindo Recent Development
11.5 Avadel
11.5.1 Avadel Company Detail
11.5.2 Avadel Business Overview
11.5.3 Avadel Sustained Release Injectables Introduction
11.5.4 Avadel Revenue in Sustained Release Injectables Business (2019-2024)
11.5.5 Avadel Recent Development
11.6 Alkermes
11.6.1 Alkermes Company Detail
11.6.2 Alkermes Business Overview
11.6.3 Alkermes Sustained Release Injectables Introduction
11.6.4 Alkermes Revenue in Sustained Release Injectables Business (2019-2024)
11.6.5 Alkermes Recent Development
11.7 Amylin Pharmaceuticals
11.7.1 Amylin Pharmaceuticals Company Detail
11.7.2 Amylin Pharmaceuticals Business Overview
11.7.3 Amylin Pharmaceuticals Sustained Release Injectables Introduction
11.7.4 Amylin Pharmaceuticals Revenue in Sustained Release Injectables Business (2019-2024)
11.7.5 Amylin Pharmaceuticals Recent Development
11.8 Biomarin
11.8.1 Biomarin Company Detail
11.8.2 Biomarin Business Overview
11.8.3 Biomarin Sustained Release Injectables Introduction
11.8.4 Biomarin Revenue in Sustained Release Injectables Business (2019-2024)
11.8.5 Biomarin Recent Development
11.9 Camurus
11.9.1 Camurus Company Detail
11.9.2 Camurus Business Overview
11.9.3 Camurus Sustained Release Injectables Introduction
11.9.4 Camurus Revenue in Sustained Release Injectables Business (2019-2024)
11.9.5 Camurus Recent Development
11.10 Critical Pharmaceuticals
11.10.1 Critical Pharmaceuticals Company Detail
11.10.2 Critical Pharmaceuticals Business Overview
11.10.3 Critical Pharmaceuticals Sustained Release Injectables Introduction
11.10.4 Critical Pharmaceuticals Revenue in Sustained Release Injectables Business (2019-2024)
11.10.5 Critical Pharmaceuticals Recent Development
11.11 Durect
11.11.1 Durect Company Detail
11.11.2 Durect Business Overview
11.11.3 Durect Sustained Release Injectables Introduction
11.11.4 Durect Revenue in Sustained Release Injectables Business (2019-2024)
11.11.5 Durect Recent Development
11.12 Eli Lilly
11.12.1 Eli Lilly Company Detail
11.12.2 Eli Lilly Business Overview
11.12.3 Eli Lilly Sustained Release Injectables Introduction
11.12.4 Eli Lilly Revenue in Sustained Release Injectables Business (2019-2024)
11.12.5 Eli Lilly Recent Development
11.13 Enzon
11.13.1 Enzon Company Detail
11.13.2 Enzon Business Overview
11.13.3 Enzon Sustained Release Injectables Introduction
11.13.4 Enzon Revenue in Sustained Release Injectables Business (2019-2024)
11.13.5 Enzon Recent Development
11.14 Ipsen
11.14.1 Ipsen Company Detail
11.14.2 Ipsen Business Overview
11.14.3 Ipsen Sustained Release Injectables Introduction
11.14.4 Ipsen Revenue in Sustained Release Injectables Business (2019-2024)
11.14.5 Ipsen Recent Development
11.15 InnoCore Pharmaceuticals
11.15.1 InnoCore Pharmaceuticals Company Detail
11.15.2 InnoCore Pharmaceuticals Business Overview
11.15.3 InnoCore Pharmaceuticals Sustained Release Injectables Introduction
11.15.4 InnoCore Pharmaceuticals Revenue in Sustained Release Injectables Business (2019-2024)
11.15.5 InnoCore Pharmaceuticals Recent Development
11.16 Janssen
11.16.1 Janssen Company Detail
11.16.2 Janssen Business Overview
11.16.3 Janssen Sustained Release Injectables Introduction
11.16.4 Janssen Revenue in Sustained Release Injectables Business (2019-2024)
11.16.5 Janssen Recent Development
11.17 Merck
11.17.1 Merck Company Detail
11.17.2 Merck Business Overview
11.17.3 Merck Sustained Release Injectables Introduction
11.17.4 Merck Revenue in Sustained Release Injectables Business (2019-2024)
11.17.5 Merck Recent Development
11.18 NanOlogy
11.18.1 NanOlogy Company Detail
11.18.2 NanOlogy Business Overview
11.18.3 NanOlogy Sustained Release Injectables Introduction
11.18.4 NanOlogy Revenue in Sustained Release Injectables Business (2019-2024)
11.18.5 NanOlogy Recent Development
11.19 Novartis
11.19.1 Novartis Company Detail
11.19.2 Novartis Business Overview
11.19.3 Novartis Sustained Release Injectables Introduction
11.19.4 Novartis Revenue in Sustained Release Injectables Business (2019-2024)
11.19.5 Novartis Recent Development
11.20 Oakwood Laboratories/PharmaSophia
11.20.1 Oakwood Laboratories/PharmaSophia Company Detail
11.20.2 Oakwood Laboratories/PharmaSophia Business Overview
11.20.3 Oakwood Laboratories/PharmaSophia Sustained Release Injectables Introduction
11.20.4 Oakwood Laboratories/PharmaSophia Revenue in Sustained Release Injectables Business (2019-2024)
11.20.5 Oakwood Laboratories/PharmaSophia Recent Development
11.21 OctoPlus
11.21.1 OctoPlus Company Detail
11.21.2 OctoPlus Business Overview
11.21.3 OctoPlus Sustained Release Injectables Introduction
11.21.4 OctoPlus Revenue in Sustained Release Injectables Business (2019-2024)
11.21.5 OctoPlus Recent Development
11.22 Pacira
11.22.1 Pacira Company Detail
11.22.2 Pacira Business Overview
11.22.3 Pacira Sustained Release Injectables Introduction
11.22.4 Pacira Revenue in Sustained Release Injectables Business (2019-2024)
11.22.5 Pacira Recent Development
11.23 PhaseBio Pharmaceuticals
11.23.1 PhaseBio Pharmaceuticals Company Detail
11.23.2 PhaseBio Pharmaceuticals Business Overview
11.23.3 PhaseBio Pharmaceuticals Sustained Release Injectables Introduction
11.23.4 PhaseBio Pharmaceuticals Revenue in Sustained Release Injectables Business (2019-2024)
11.23.5 PhaseBio Pharmaceuticals Recent Development
11.24 Recipharm AB
11.24.1 Recipharm AB Company Detail
11.24.2 Recipharm AB Business Overview
11.24.3 Recipharm AB Sustained Release Injectables Introduction
11.24.4 Recipharm AB Revenue in Sustained Release Injectables Business (2019-2024)
11.24.5 Recipharm AB Recent Development
11.25 Roche
11.25.1 Roche Company Detail
11.25.2 Roche Business Overview
11.25.3 Roche Sustained Release Injectables Introduction
11.25.4 Roche Revenue in Sustained Release Injectables Business (2019-2024)
11.25.5 Roche Recent Development
11.26 Sanofi
11.26.1 Sanofi Company Detail
11.26.2 Sanofi Business Overview
11.26.3 Sanofi Sustained Release Injectables Introduction
11.26.4 Sanofi Revenue in Sustained Release Injectables Business (2019-2024)
11.26.5 Sanofi Recent Development
11.27 Taiwan Liposome Company (TLC)
11.27.1 Taiwan Liposome Company (TLC) Company Detail
11.27.2 Taiwan Liposome Company (TLC) Business Overview
11.27.3 Taiwan Liposome Company (TLC) Sustained Release Injectables Introduction
11.27.4 Taiwan Liposome Company (TLC) Revenue in Sustained Release Injectables Business (2019-2024)
11.27.5 Taiwan Liposome Company (TLC) Recent Development
11.28 Xbrane Biopharma
11.28.1 Xbrane Biopharma Company Detail
11.28.2 Xbrane Biopharma Business Overview
11.28.3 Xbrane Biopharma Sustained Release Injectables Introduction
11.28.4 Xbrane Biopharma Revenue in Sustained Release Injectables Business (2019-2024)
11.28.5 Xbrane Biopharma Recent Development
11.29 Livzon Pharm
11.29.1 Livzon Pharm Company Detail
11.29.2 Livzon Pharm Business Overview
11.29.3 Livzon Pharm Sustained Release Injectables Introduction
11.29.4 Livzon Pharm Revenue in Sustained Release Injectables Business (2019-2024)
11.29.5 Livzon Pharm Recent Development
11.30 Luye Pharma Group
11.30.1 Luye Pharma Group Company Detail
11.30.2 Luye Pharma Group Business Overview
11.30.3 Luye Pharma Group Sustained Release Injectables Introduction
11.30.4 Luye Pharma Group Revenue in Sustained Release Injectables Business (2019-2024)
11.30.5 Luye Pharma Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Ascendis Pharma
Astrazeneca plc
Aurobindo
Avadel
Alkermes plc
Amylin Pharmaceuticals
BioMarin
Camurus AB
Critical Pharmaceuticals
DURECT
Eli Lilly
Enzon, Inc.
Ipsen S A
Innocore Pharmaceuticals
Janssen
Merck
NanOlogy
Novartis
Pacira
PhaseBio Pharmaceuticals
Recipharm
Roche
Sanofi
Xbrane Biopharma
Livzon Pharm
Luye Pharma Group
AntriaBio
Oakwood Laboratories/PharmaSophia
OctoPlus
Taiwan Liposome Company (TLC)
List of Tables
    Table 1. Global Sustained Release Injectables Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Microparticles
    Table 3. Key Players of Implants
    Table 4. Key Players of Gels
    Table 5. Global Sustained Release Injectables Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Sustained Release Injectables Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Sustained Release Injectables Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Sustained Release Injectables Market Share by Region (2019-2024)
    Table 9. Global Sustained Release Injectables Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Sustained Release Injectables Market Share by Region (2025-2030)
    Table 11. Sustained Release Injectables Market Trends
    Table 12. Sustained Release Injectables Market Drivers
    Table 13. Sustained Release Injectables Market Challenges
    Table 14. Sustained Release Injectables Market Restraints
    Table 15. Global Sustained Release Injectables Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Sustained Release Injectables Market Share by Players (2019-2024)
    Table 17. Global Top Sustained Release Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained Release Injectables as of 2023)
    Table 18. Ranking of Global Top Sustained Release Injectables Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by Sustained Release Injectables Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Sustained Release Injectables Product Solution and Service
    Table 22. Date of Enter into Sustained Release Injectables Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Sustained Release Injectables Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Sustained Release Injectables Revenue Market Share by Type (2019-2024)
    Table 26. Global Sustained Release Injectables Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Sustained Release Injectables Revenue Market Share by Type (2025-2030)
    Table 28. Global Sustained Release Injectables Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Sustained Release Injectables Revenue Market Share by Application (2019-2024)
    Table 30. Global Sustained Release Injectables Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Sustained Release Injectables Revenue Market Share by Application (2025-2030)
    Table 32. North America Sustained Release Injectables Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America Sustained Release Injectables Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America Sustained Release Injectables Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe Sustained Release Injectables Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe Sustained Release Injectables Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe Sustained Release Injectables Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific Sustained Release Injectables Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific Sustained Release Injectables Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific Sustained Release Injectables Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America Sustained Release Injectables Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America Sustained Release Injectables Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America Sustained Release Injectables Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa Sustained Release Injectables Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa Sustained Release Injectables Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa Sustained Release Injectables Market Size by Country (2025-2030) & (US$ Million)
    Table 47. AntriaBio Company Detail
    Table 48. AntriaBio Business Overview
    Table 49. AntriaBio Sustained Release Injectables Product
    Table 50. AntriaBio Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 51. AntriaBio Recent Development
    Table 52. Ascendis Pharma Company Detail
    Table 53. Ascendis Pharma Business Overview
    Table 54. Ascendis Pharma Sustained Release Injectables Product
    Table 55. Ascendis Pharma Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 56. Ascendis Pharma Recent Development
    Table 57. AstraZeneca Company Detail
    Table 58. AstraZeneca Business Overview
    Table 59. AstraZeneca Sustained Release Injectables Product
    Table 60. AstraZeneca Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 61. AstraZeneca Recent Development
    Table 62. Aurobindo Company Detail
    Table 63. Aurobindo Business Overview
    Table 64. Aurobindo Sustained Release Injectables Product
    Table 65. Aurobindo Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 66. Aurobindo Recent Development
    Table 67. Avadel Company Detail
    Table 68. Avadel Business Overview
    Table 69. Avadel Sustained Release Injectables Product
    Table 70. Avadel Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 71. Avadel Recent Development
    Table 72. Alkermes Company Detail
    Table 73. Alkermes Business Overview
    Table 74. Alkermes Sustained Release Injectables Product
    Table 75. Alkermes Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 76. Alkermes Recent Development
    Table 77. Amylin Pharmaceuticals Company Detail
    Table 78. Amylin Pharmaceuticals Business Overview
    Table 79. Amylin Pharmaceuticals Sustained Release Injectables Product
    Table 80. Amylin Pharmaceuticals Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 81. Amylin Pharmaceuticals Recent Development
    Table 82. Biomarin Company Detail
    Table 83. Biomarin Business Overview
    Table 84. Biomarin Sustained Release Injectables Product
    Table 85. Biomarin Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 86. Biomarin Recent Development
    Table 87. Camurus Company Detail
    Table 88. Camurus Business Overview
    Table 89. Camurus Sustained Release Injectables Product
    Table 90. Camurus Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 91. Camurus Recent Development
    Table 92. Critical Pharmaceuticals Company Detail
    Table 93. Critical Pharmaceuticals Business Overview
    Table 94. Critical Pharmaceuticals Sustained Release Injectables Product
    Table 95. Critical Pharmaceuticals Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 96. Critical Pharmaceuticals Recent Development
    Table 97. Durect Company Detail
    Table 98. Durect Business Overview
    Table 99. Durect Sustained Release Injectables Product
    Table 100. Durect Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 101. Durect Recent Development
    Table 102. Eli Lilly Company Detail
    Table 103. Eli Lilly Business Overview
    Table 104. Eli Lilly Sustained Release Injectables Product
    Table 105. Eli Lilly Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 106. Eli Lilly Recent Development
    Table 107. Enzon Company Detail
    Table 108. Enzon Business Overview
    Table 109. Enzon Sustained Release Injectables Product
    Table 110. Enzon Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 111. Enzon Recent Development
    Table 112. Ipsen Company Detail
    Table 113. Ipsen Business Overview
    Table 114. Ipsen Sustained Release Injectables Product
    Table 115. Ipsen Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 116. Ipsen Recent Development
    Table 117. InnoCore Pharmaceuticals Company Detail
    Table 118. InnoCore Pharmaceuticals Business Overview
    Table 119. InnoCore Pharmaceuticals Sustained Release Injectables Product
    Table 120. InnoCore Pharmaceuticals Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 121. InnoCore Pharmaceuticals Recent Development
    Table 122. Janssen Company Detail
    Table 123. Janssen Business Overview
    Table 124. Janssen Sustained Release Injectables Product
    Table 125. Janssen Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 126. Janssen Recent Development
    Table 127. Merck Company Detail
    Table 128. Merck Business Overview
    Table 129. Merck Sustained Release Injectables Product
    Table 130. Merck Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 131. Merck Recent Development
    Table 132. NanOlogy Company Detail
    Table 133. NanOlogy Business Overview
    Table 134. NanOlogy Sustained Release Injectables Product
    Table 135. NanOlogy Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 136. NanOlogy Recent Development
    Table 137. Novartis Company Detail
    Table 138. Novartis Business Overview
    Table 139. Novartis Sustained Release Injectables Product
    Table 140. Novartis Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 141. Novartis Recent Development
    Table 142. Oakwood Laboratories/PharmaSophia Company Detail
    Table 143. Oakwood Laboratories/PharmaSophia Business Overview
    Table 144. Oakwood Laboratories/PharmaSophia Sustained Release Injectables Product
    Table 145. Oakwood Laboratories/PharmaSophia Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 146. Oakwood Laboratories/PharmaSophia Recent Development
    Table 147. OctoPlus Company Detail
    Table 148. OctoPlus Business Overview
    Table 149. OctoPlus Sustained Release Injectables Product
    Table 150. OctoPlus Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 151. OctoPlus Recent Development
    Table 152. Pacira Company Detail
    Table 153. Pacira Business Overview
    Table 154. Pacira Sustained Release Injectables Product
    Table 155. Pacira Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 156. Pacira Recent Development
    Table 157. PhaseBio Pharmaceuticals Company Detail
    Table 158. PhaseBio Pharmaceuticals Business Overview
    Table 159. PhaseBio Pharmaceuticals Sustained Release Injectables Product
    Table 160. PhaseBio Pharmaceuticals Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 161. PhaseBio Pharmaceuticals Recent Development
    Table 162. Recipharm AB Company Detail
    Table 163. Recipharm AB Business Overview
    Table 164. Recipharm AB Sustained Release Injectables Product
    Table 165. Recipharm AB Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 166. Recipharm AB Recent Development
    Table 167. Roche Company Detail
    Table 168. Roche Business Overview
    Table 169. Roche Sustained Release Injectables Product
    Table 170. Roche Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 171. Roche Recent Development
    Table 172. Sanofi Company Detail
    Table 173. Sanofi Business Overview
    Table 174. Sanofi Sustained Release Injectables Product
    Table 175. Sanofi Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 176. Sanofi Recent Development
    Table 177. Taiwan Liposome Company (TLC) Company Detail
    Table 178. Taiwan Liposome Company (TLC) Business Overview
    Table 179. Taiwan Liposome Company (TLC) Sustained Release Injectables Product
    Table 180. Taiwan Liposome Company (TLC) Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 181. Taiwan Liposome Company (TLC) Recent Development
    Table 182. Xbrane Biopharma Company Detail
    Table 183. Xbrane Biopharma Business Overview
    Table 184. Xbrane Biopharma Sustained Release Injectables Product
    Table 185. Xbrane Biopharma Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 186. Xbrane Biopharma Recent Development
    Table 187. Livzon Pharm Company Detail
    Table 188. Livzon Pharm Business Overview
    Table 189. Livzon Pharm Sustained Release Injectables Product
    Table 190. Livzon Pharm Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 191. Livzon Pharm Recent Development
    Table 192. Luye Pharma Group Company Detail
    Table 193. Luye Pharma Group Business Overview
    Table 194. Luye Pharma Group Sustained Release Injectables Product
    Table 195. Luye Pharma Group Revenue in Sustained Release Injectables Business (2019-2024) & (US$ Million)
    Table 196. Luye Pharma Group Recent Development
    Table 197. Research Programs/Design for This Report
    Table 198. Key Data Information from Secondary Sources
    Table 199. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sustained Release Injectables Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Sustained Release Injectables Market Share by Type: 2023 VS 2030
    Figure 3. Microparticles Features
    Figure 4. Implants Features
    Figure 5. Gels Features
    Figure 6. Global Sustained Release Injectables Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Sustained Release Injectables Market Share by Application: 2023 VS 2030
    Figure 8. Diabetes Case Studies
    Figure 9. Leukemia Case Studies
    Figure 10. Acromegaly Case Studies
    Figure 11. Ophthalmology Case Studies
    Figure 12. CNS Case Studies
    Figure 13. Rheumatology Case Studies
    Figure 14. Oncology Case Studies
    Figure 15. Reproductive Health Case Studies
    Figure 16. Others Case Studies
    Figure 17. Sustained Release Injectables Report Years Considered
    Figure 18. Global Sustained Release Injectables Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 19. Global Sustained Release Injectables Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 20. Global Sustained Release Injectables Market Share by Region: 2023 VS 2030
    Figure 21. Global Sustained Release Injectables Market Share by Players in 2023
    Figure 22. Global Top Sustained Release Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained Release Injectables as of 2023)
    Figure 23. The Top 10 and 5 Players Market Share by Sustained Release Injectables Revenue in 2023
    Figure 24. North America Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. North America Sustained Release Injectables Market Share by Country (2019-2030)
    Figure 26. United States Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Canada Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Europe Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Europe Sustained Release Injectables Market Share by Country (2019-2030)
    Figure 30. Germany Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Asia-Pacific Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Asia-Pacific Sustained Release Injectables Market Share by Region (2019-2030)
    Figure 38. China Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Japan Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. South Korea Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Southeast Asia Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. India Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Australia Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Latin America Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Latin America Sustained Release Injectables Market Share by Country (2019-2030)
    Figure 46. Mexico Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Brazil Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East & Africa Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Sustained Release Injectables Market Share by Country (2019-2030)
    Figure 50. Turkey Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Saudi Arabia Sustained Release Injectables Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. AntriaBio Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 53. Ascendis Pharma Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 54. AstraZeneca Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 55. Aurobindo Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 56. Avadel Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 57. Alkermes Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 58. Amylin Pharmaceuticals Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 59. Biomarin Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 60. Camurus Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 61. Critical Pharmaceuticals Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 62. Durect Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 63. Eli Lilly Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 64. Enzon Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 65. Ipsen Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 66. InnoCore Pharmaceuticals Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 67. Janssen Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 68. Merck Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 69. NanOlogy Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 70. Novartis Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 71. Oakwood Laboratories/PharmaSophia Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 72. OctoPlus Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 73. Pacira Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 74. PhaseBio Pharmaceuticals Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 75. Recipharm AB Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 76. Roche Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 77. Sanofi Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 78. Taiwan Liposome Company (TLC) Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 79. Xbrane Biopharma Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 80. Livzon Pharm Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 81. Luye Pharma Group Revenue Growth Rate in Sustained Release Injectables Business (2019-2024)
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Sustained release Medicine Market Research Report 2025
Global Sustained Release Excipients Market Insights Forecast to 2030
Global Injectable Drug Delivery Market Research Report 2024
Global Sustained Release Coatings Market Insights Forecast to 2030
Global Sustained and Controlled Release Formulations Market Research Report 2025
Generic Injectables Market
Global Pharmaceutical Excipients for Oral Formulations Market Research Report 2024
Global Oral Sustained and Controlled Release Formulations Market Research Report 2025
Global Parenteral Pharmaceutical Suspensions Market Research Report 2024
Global Soft Implantable Drug Delivery System Market Research Report 2024
Global Drug Delivery Technology Market Research Report 2024
Global Generic Injectable Drugs Market Research Report 2024
Sustained Release Film Coating Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Injectable Drug Delivery Equipment Market Insights Forecast to 2030
Global Biodegradable Implantable Drug Delivery System Market Research Report 2024
Injectable Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liquid Formulation Capsule Market Research Report 2025
Global Microsphere Injection Preparation Market Research Report 2024
Global Sterile Injectable Drugs Market Research Report 2024
Global Liquid Formulations Drug Delivery Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions